Press release
BIS Research Unveils U.S. Surgical Procedure Volume Tracker - Parkinson's Disease Insights 2016-2024

The report highlights a steady rise in Parkinson's-related surgical procedures due to the growing prevalence of the disease, technological advancements in neuromodulation, and expanding clinical adoption of minimally invasive surgical approaches. The Surg
BIS Research has released new data from its U.S. Surgical Procedure Volume Tracker [https://info.bisresearch.com/surgical-procedure-volume-database-by-bis-research?utm_source=Monika+Abnewswire&utm_medium=Abnewswire&utm_campaign=Monika_pr], highlighting patient dynamics and hospitalization trends associated with Parkinson's disease from 2016 through 2024.
The findings reflect the ongoing evolution of disease incidence, patient care patterns, and hospital utilization across the United States - offering valuable insights for healthcare providers, policymakers, and pharmaceutical developers focused on neurodegenerative conditions.
Rising Incidence and Prevalence of Parkinson's Disease
According to the Patient Dynamics Database (U.S.), the annual incidence of Parkinson's disease has grown steadily over the past nine years.
*
2016: 81,567 new cases
*
2024: 90,819 new cases
This represents a cumulative increase of over 11%, signaling a growing need for neurological care, specialized surgical interventions, and long-term patient management programs.
Similarly, disease prevalence-the total number of patients living with Parkinson's-rose from 855,690 cases in 2016 to an estimated 936,997 in 2024, underscoring both improved survival rates and the chronic progression of the condition.
Hospital and Patient Care Utilization Trends
BIS Research's U.S. Surgical Procedure Volume Tracker also captures the shifting dynamics of hospital-based care and outpatient management among Parkinson's patients.
Category
2016
2020
2024
ED Visits
22,088
22,792
26,275
Other Hospital Admissions
9,515
6,999
8,607
ED to Hospital Admissions
11,174
11,870
13,784
Total Hospital Admissions
20,689
18,869
22,391
Ambulatory Care Visits
4,071
3,785
4,201
The data indicates a gradual rebound in hospital utilization following pandemic-era declines, particularly between 2020 and 2024. Emergency department (ED) visits have grown by nearly 19% since 2016, reflecting increasing reliance on acute neurological care.
Conversely, fluctuations in "Other Hospital Admissions" and "Ambulatory Care" highlight ongoing transitions toward outpatient management, home-based care, and neurology specialty programs aimed at improving patient quality of life while reducing hospital burden.
Drive Smarter Decisions - Get the Database Today - Request a Quote [https://share.hsforms.com/1Z2XHVXfQRFGe6vKHXOLrEA3sid0?hsCtaAttrib=192132547972&utm_source=abnewswireMonika&utm_medium=Abnewswire&utm_campaign=Monika_pr]
What the Data Means for the U.S. Healthcare Ecosystem
The consistent increase in Parkinson's incidence and hospital encounters points to both progress and pressure within the healthcare system:
*
Progress, because early diagnosis and improved patient survival are expanding the treatment population.
*
Pressure, because higher patient volumes are driving up demand for neurology specialists, physical rehabilitation, and surgical intervention infrastructure.
As part of BIS Research's U.S. Surgical Procedure Volume Tracker, these datasets enable stakeholders to:
*
Forecast surgical and hospital workload related to Parkinson's and other neurodegenerative diseases.
*
Analyze regional patient access, hospital capacity, and procedure readiness.
*
Identify strategic opportunities for device manufacturers, digital health providers, and pharma companies developing Parkinson's treatments.
Gain Instant Access to U.S. Neurological Surgical Procedure Volume Data
As the U.S. healthcare system advances toward precision-based neurology and surgical innovation, access to accurate and granular procedure data has become essential. BIS Research's U.S. Neurological Surgical Procedure Volume Database empowers healthcare organizations, MedTech manufacturers, and research institutions with detailed, validated insights into Parkinson's disease dynamics and Deep Brain Stimulation (DBS) procedure volumes.
This database forms a key segment of BIS Research's Global Surgical Procedure Volume Tracker, offering hospital-level visibility and forecasting capabilities across the neurological care continuum.
Comprehensive Coverage: From Patient Dynamics to Surgical Interventions
1 U.S. Neurological Surgical Procedure Volume Data (2024)
Gain access to the most up-to-date surgical data covering neurological and neurodegenerative conditions across major hospitals in the United States. This dataset provides:
*
Detailed procedure volumes segmented by hospital type and region
*
Year-on-year growth rates from 2016 to 2024
*
Forecast models extending to 2030
*
Correlations between disease burden, treatment demand, and hospital admissions
These insights enable stakeholders to identify procedure trends, evaluate healthcare utilization, and plan resource allocation more effectively.
2 U.S. Patient Dynamics for Parkinson's Disease (2016-2024)
Understand how Parkinson's disease has evolved over the past decade through BIS Research's Patient Dynamics Database, which integrates clinical, demographic, and procedural data.
Key Insights from the 2024 Update
*
Incidence: Grew from 81,567 new cases in 2016 to 90,819 in 2024, reflecting an 11% increase.
*
Prevalence: Rose to 936,997 from 855,690 cases in the same period, underscoring longer survival rates and earlier diagnosis.
*
Emergency Department (ED) Visits: Increased from 22,088 in 2016 to 26,275 in 2024, showing heightened reliance on acute neurological care.
*
Hospital Admissions: Reached 22,391 in 2024, recovering from pandemic-related declines.
*
Ambulatory Visits: Steadily rose from 4,071 to 4,201, signaling a gradual shift toward outpatient management and home-based care.
Request a Demo [https://calendly.com/bis-research/schedule-a-call?utm_source=abnewswireMonika&utm_medium=Abnewswire&utm_campaign=Monika_pr]
What This Means
*
The Parkinson's patient population is expanding in both volume and care complexity.
*
Rising incidence reflects better diagnostic coverage and aging demographics.
*
Shifts toward outpatient care highlight the need for specialized neurology centers and surgical precision infrastructure.
3 U.S. Deep Brain Stimulation (DBS) Procedure Volume Data (2024)
Deep Brain Stimulation remains one of the most transformative surgical interventions for managing Parkinson's disease and movement disorders.
The 2024 DBS Procedure Volume Data includes:
*
Total procedures performed across major U.S. hospitals
*
Growth rates compared to 2023
*
Insights into DBS adoption patterns, regional distribution, and hospital-level adoption
*
Trends connecting patient eligibility with procedural capacity and device utilization
Strategic Value
*
Identify high-volume DBS centers for partnership, sales, or research collaboration
*
Understand geographic and institutional adoption of neurosurgical technologies
*
Track how innovations in implantable neurostimulation devices are impacting surgical demand
Why This Data Matters
The combination of patient dynamics and procedure data provides a 360-degree view of the U.S. neurology care ecosystem - from diagnosis to surgical intervention. Organizations leveraging this intelligence can:
*
Forecast hospital workload and resource needs
*
Benchmark procedure volumes and adoption trends across institutions
*
Support market entry and device strategy for MedTech and pharma firms
*
Strengthen clinical research and real-world evidence generation for Parkinson's disease and related disorders
Key Benefits of the BIS Research U.S. Neurological Data Platform
*
Hospital-Level Intelligence: Access data from over 4,000 hospitals nationwide, identifying leading surgical and neurology centers.
*
Physician-Level Insights: Map key opinion leaders (KOLs), high-performing surgeons, and procedural specialists for targeted engagement.
*
Forecasting & Trend Analysis: Leverage advanced modeling for procedure growth through 2030, based on incidence and prevalence data.
*
Integration-Ready Datasets: Delivered in analytics-friendly formats for integration with CRM, forecasting tools, or data visualization platforms.
Transforming Decision-Making in Neurology and Surgery
The U.S. Neurological Surgical Procedure Volume Database enables stakeholders to move beyond assumptions and make truly data-driven decisions. By combining clinical insights, patient dynamics, and real-world hospital intelligence, it helps bridge the gap between disease understanding and operational readiness.
Building Data-Driven Neurology Insights
This dataset is part of BIS Research's broader initiative to integrate patient-level dynamics-including incidence, prevalence, hospital admissions, and ambulatory care volumes-into its Global Surgical Procedure Volume Database. By quantifying patient interactions across the care continuum, the platform offers unparalleled intelligence for understanding how chronic diseases translate into real-world procedural and clinical workloads.
About BIS Research
BIS Research is a global market intelligence and advisory firm delivering actionable insights across healthcare, biotechnology, and advanced technology sectors. Through its Surgical Procedure Volume Database, BIS Research provides real-world, country-level datasets covering 300+ surgical procedures across 13 specialties in 40+ countries. We publish over 200 market intelligence reports across various deep technology verticals. We help businesses stay ahead with in-depth reports, custom research [https://bisresearch.com/our-offerings/custom-research?utm_source=abnewswireMonika&utm_medium=Abnewswire&utm_campaign=Monika_pr], and go-to-market strategies tailored to your goals.
Media Contact
Company Name: BIS Research
Contact Person: Bhavya Banga
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=bis-research-unveils-us-surgical-procedure-volume-tracker-parkinsons-disease-insights-20162024]
Phone: +1-510-404-8135
Address:39111 PASEO PADRE PKWY STE 313, FREMONT CA 94538
Country: United States
Website: https://info.bisresearch.com/surgical-procedure-volume-database-by-bis-research
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release BIS Research Unveils U.S. Surgical Procedure Volume Tracker - Parkinson's Disease Insights 2016-2024 here
News-ID: 4288267 • Views: …
More Releases from ABNewswire
Laminated Glass Market Size, Competitor Ranking Analysis, Market Trend Forecast …
The Laminated Glass market is growing strongly as demand rises for enhanced safety, acoustic control, and UV protection in automotive, construction, and architectural applications. Its durability and security benefits are driving widespread adoption. Key players such as Saint-Gobain, AGC Inc., Guardian Glass, NSG Group, and Fuyao Glass are leading advancements in high-performance and energy-efficient laminated glass solutions.
The laminated glass market is expected to grow from USD 31.68 billion in 2024…
Steel Wire Rope Market Size, Share, Growth, Trends, Outlook and Report 2025-2030 …
The Steel Wire Rope market is witnessing strong growth fueled by expanding construction, mining, oil & gas, and marine applications that require high-strength, durable lifting and rigging solutions. Increasing infrastructure investments further boost demand. Key players such as WireCo WorldGroup, Kiswire, Bridon-Bekaert, Usha Martin, and Tokyo Rope are enhancing product performance and safety to meet global industry standards.
The global steel wire rope market is projected to reach USD 13.88 billion…
Penetration Testing Market Leading Companies, Growth Factors, Healthy CAGR, Oppo …
Penetration Testing Market by Offering (Solution, Services), Type (Web Applications, Mobile Applications, Network Infrastructure, Social Engineering, Cloud), Organization Size, Deployment Mode, Vertical and Region - Global Forecast to 2029.
The Penetration Testing Market [https://www.marketsandmarkets.com/Market-Reports/penetration-testing-market-13422019.html?utm_campaign=penetrationtestingmarket&utm_source=abnewswire.com&utm_medium=referral] is expected to expand at a Compound Annual Growth Rate (CAGR) of 17.1% from USD 1.7 billion in 2024 to USD 3.9 billion by 2029. The market for penetration testing is growing due to the constantly changing…
McKayLawTx.com is the top rated 18 Wheel Truck accident Lawyer in Greenville, Su …
McKayLawTx.com exclusive Investigation Methods Expose Critical Tractor-Trailer System Failures Most Attorneys Miss- McKay Law is the East Texas, Greenville, Paris and Sulphur Springs, TX Premier Truck Accident Firm.The firm's revolutionary methodology delivers settlement values averaging 2.8 times higher and jury verdicts 3.4 times higher than industry norms, fundamentally changing the landscape of commercial vehicle litigation in Texas.
SULPHUR SPRINGS, TX - November 25, 2025 - McKay Law PLLC today unveiled comprehensive…
More Releases for Parkinson
Key Trends Reshaping the Wolff Parkinson White Syndrome Market: Technological Ad …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
Wolff Parkinson White Syndrome Market Size Growth Forecast: What to Expect by 2025?
The market for Wolff Parkinson White syndrome has registered consistent growth over the recent past. The expectation is that it will expand from $1.17 billion in 2024 to $1.22 billion in 2025, reflecting a compound annual growth rate (CAGR) of 4.5%.…
Evolving Market Trends In The Anti-Parkinson Drugs Industry: Innovative Advancem …
The Anti-Parkinson Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Anti-Parkinson Drugs Market Size During the Forecast Period?
The anti-parkinson drugs market has seen significant growth in recent years, projected to increase from $10.37 billion in 2024 to $11.08 billion in…
What's Driving the Anti-Parkinson Drugs Market 2025-2034: Increasing Geriatric P …
What Are the Projections for the Size and Growth Rate of the Anti-Parkinson Drugs Market?
In recent times, the market size for anti-Parkinson drugs has experienced robust growth. The market, which is projected to rise from $10.37 billion in 2024 to $11.08 billion in 2025, boasts a compound annual growth rate (CAGR) of 6.9%. The past growth trend can be credited to an aging demographic, a surge in disease incidence, enhanced…
What's Driving the Anti-Parkinson Drugs Market 2025-2034: Increasing Geriatric P …
What Are the Projections for the Size and Growth Rate of the Anti-Parkinson Drugs Market?
In recent times, the market size for anti-Parkinson drugs has experienced robust growth. The market, which is projected to rise from $10.37 billion in 2024 to $11.08 billion in 2025, boasts a compound annual growth rate (CAGR) of 6.9%. The past growth trend can be credited to an aging demographic, a surge in disease incidence, enhanced…
Wolff Parkinson White Syndrome Treatment Market Overview 2024-2033
The Business Research Company has recently revised its global market reports, now incorporating the most current data for 2024 along with projections extending up to 2033.
Wolff Parkinson White Syndrome Global Market Report 2024 by The Business Research Company offers comprehensive market insights, empowering businesses with a competitive edge. It includes detailed estimates for numerous segments and sub-segments, providing valuable strategic guidance.
The Market Size Is Expected To Reach $1.43 billion…
Anti-Parkinson Drugs Market Overview
Exhibiting robust growth, the anti-parkinson drugs market is set to escalate from $9.73 billion in 2023 to $10.43 billion in 2024, with a notable Compound Annual Growth Rate (CAGR) of 7.2%. The trajectory continues on an upward trend, with an anticipated market size of $13.36 billion by 2028, sustaining a robust CAGR of 6.4%.
Increasing Geriatric Population Driving Demand:
The burgeoning geriatric population, coupled with a surge in Parkinson's disease cases,…